Data Sharing as Part of the Normal Scientific Process: A View from the Pharmaceutical Industry

English version České info

Reflecting on the WHO consultation on developing global norms for sharing data and results during public health emergencies, Patrick Vallance and colleagues argue that there are significant benefits to the principle of data sharing.

Vyšlo v časopise: Data Sharing as Part of the Normal Scientific Process: A View from the Pharmaceutical Industry. PLoS Med 13(1): e32767. doi:10.1371/journal.pmed.1001936
Kategorie: Perspective
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pmed.1001936

Souhrn

Zdroje

1. Modjarrad K, Moorthy VS, Millet P, Gsell P-S, Roth C, Kieny M-P. Developing global norms for sharing data and results during public health emergencies. PLoS Med 2015; 13(1);e1001935. doi: 10.1371/journal.pmed.1001935

2. The Royal Society. Science as an open enterprise. https://royalsociety.org/~/media/policy/projects/sape/2012-06-20-saoe.pdf

3. Institute of Medicine. Sharing clinical trial data: maximizing benefit, minimizing risk. http://iom.nationalacademies.org/Reports/2015/Sharing-Clinical-Trial-Data.aspx

4. Nisen P, Rockhold F. Access to patient-level data from GlaxoSmithKline clinical trials. N Engl J Med 2013; 369: 475–478. doi: 10.1056/NEJMsr1302541 23902490

5. Gamo F-J, Sanz LM, Vidal J, de Cozar C, Alvarez E, Lavandera J-L et al (2010). Thousands of chemical starting points for antimalarial lead identification. Nature 2010; 465 (7296): 305–310. doi: 10.1038/nature09107 20485427

6. Borysiewicz L, Strange M, Atun R. Breaking the R&D deadlock: could Open Labs be the key to cracking the world’s toughest health problems? The Lancet Global Health Blog [Internet] 14th November 2014. http://globalhealth.thelancet.com/2014/11/14/breaking-rd-deadlock-could-open-labs-be-key-cracking-worlds-toughest-health-problems

7. Vallance P, Chalmers I. Secure use of individual patient data from clinical trials. The Lancet 2013; 382: 1073–1074.